Monte Rosa Therapeutics, Inc. (GLUE) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 677.55M | 393.19M | 401.82M | 299.46M | 332.28M | 377.44M | 251.21M | 277.9M | 199.04M | 236.21M | 182.91M | 208.1M |
| Cash & Short-Term Investments | 666.22M | 377.1M | 391.26M | 290.59M | 326.07M | 372.15M | 242.19M | 262.2M | 192.89M | 232.41M | 178.48M | 203.07M |
| Cash Only | 159.86M | 129.88M | 208.34M | 69.43M | 78.53M | 224.25M | 125.58M | 108.85M | 99.75M | 128.1M | 59.05M | 47.03M |
| Short-Term Investments | 506.36M | 247.22M | 182.91M | 221.16M | 247.54M | 147.9M | 116.61M | 153.36M | 93.14M | 104.31M | 119.42M | 156.04M |
| Accounts Receivable | 4.61M | 4.6M | 4.96M | 2.37M | 1.41M | 173K | 595K | 9.84M | 601K | 505K | 294K | 1.15M |
| Days Sales Outstanding | 98.43 | 158.21 | 26.43 | 7.41 | 0.84 | 0.58 | 52.09 | 101.2 | 47.3 | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.72M | 11.48M | 5.59M | 6.5M | 4.8M | 5.12M | 8.43M | 5.85M | 5.54M | 3.29M | 4.14M | 3.88M |
| Total Non-Current Assets | 58.88M | 55.47M | 58.02M | 60.12M | 60.92M | 61.29M | 63.87M | 66.22M | 67.71M | 67.54M | 69.19M | 70.51M |
| Property, Plant & Equipment | 53.1M | 50.37M | 52.66M | 54.73M | 55.6M | 56.31M | 58.81M | 61.14M | 62.46M | 62.61M | 64.4M | 65.69M |
| Fixed Asset Turnover | 0.08x | 0.05x | 0.24x | 0.42x | 1.52x | 1.05x | 0.15x | 0.08x | 0.02x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 4.95M | 0 | 0 | 4.91M | 4.87M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5.78M | 5.1M | 5.36M | 445K | 5.32M | 4.98M | 159K | 209K | 5.25M | 4.93M | 4.79M | 4.82M |
| Total Assets | 736.43M | 448.66M | 459.84M | 359.59M | 393.2M | 438.73M | 315.08M | 344.11M | 266.75M | 303.75M | 252.1M | 278.62M |
| Asset Turnover | 0.01x | 0.01x | 0.03x | 0.06x | 0.20x | 0.16x | 0.03x | 0.02x | 0.00x | - | - | - |
| Asset Growth % | 87.29% | 2.26% | 45.94% | 4.5% | 47.41% | 44.44% | 24.98% | 23.51% | -13.68% | -11.28% | -29.5% | -23.68% |
| Total Current Liabilities | 71.04M | 64.21M | 61.44M | 41.85M | 59.22M | 156.95M | 41.64M | 42.35M | 41.29M | 46.59M | 22.61M | 19.09M |
| Accounts Payable | 7.9M | 3.55M | 14.51M | 5.58M | 6.49M | 17.21M | 3.98M | 6.47M | 6.83M | 11.15M | 5.5M | 5.31M |
| Days Payables Outstanding | 253.94 | - | - | - | - | - | - | 293.78 | 431.25 | - | - | - |
| Short-Term Debt | 4.48M | 4.4M | 4.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 33.06M | 29.57M | 24.79M | 18.41M | 32.58M | 117.23M | 18.92M | 19.64M | 20.41M | 17.68M | 0 | 0 |
| Other Current Liabilities | 25.59M | 26.69M | 17.9M | 8.64M | 8.26M | 11.57M | 15.1M | 7.62M | 5.7M | 9.26M | 9.05M | 6.92M |
| Current Ratio | 9.54x | 6.12x | 6.54x | 7.16x | 5.61x | 2.40x | 6.03x | 6.56x | 4.82x | 5.07x | 8.09x | 10.90x |
| Quick Ratio | 9.54x | 6.12x | 6.54x | 7.16x | 5.61x | 2.40x | 6.03x | 6.56x | 4.82x | 5.07x | 8.09x | 10.90x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 143.48M | 151.39M | 152.56M | 49.65M | 58.82M | 58.85M | 67.98M | 77.09M | 72.93M | 77.91M | 44.97M | 45.87M |
| Long-Term Debt | 34.58M | 34.79M | 35.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 37.04M | 38M | 39M | 40.05M | 40.88M | 41.84M | 42.88M | 43.52M | 44.37M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 108.89M | 5.26M | 116.63M | 4.56M | 3.96M | 3.7M | 2.82M | 2.61M | 2.57M | 2.71M | 1.45M | 1.5M |
| Total Liabilities | 214.51M | 215.6M | 214M | 91.51M | 118.04M | 215.8M | 109.62M | 119.44M | 114.23M | 124.5M | 67.58M | 64.96M |
| Total Debt | 39.06M | 39.19M | 40.17M | 41.13M | 41.86M | 42.72M | 43.7M | 44.36M | 45.18M | 46.04M | 46.4M | 47.03M |
| Net Debt | -120.8M | -90.69M | -168.18M | -28.3M | -36.67M | -181.54M | -81.88M | -64.49M | -54.57M | -82.06M | -12.66M | 8K |
| Debt / Equity | 0.07x | 0.17x | 0.16x | 0.15x | 0.15x | 0.19x | 0.21x | 0.20x | 0.30x | 0.26x | 0.25x | 0.22x |
| Debt / EBITDA | - | - | - | - | 0.91x | 2.84x | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | -0.80x | -12.05x | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 521.92M | 233.06M | 245.84M | 268.08M | 275.16M | 222.94M | 205.46M | 224.67M | 152.52M | 179.25M | 184.52M | 213.65M |
| Equity Growth % | 89.68% | 4.54% | 19.65% | 19.32% | 80.41% | 24.37% | 11.34% | 5.16% | -37.42% | -33.96% | -36.61% | -29.27% |
| Book Value per Share | 7.96 | 3.56 | 2.98 | 3.26 | 3.32 | 3.63 | 2.51 | 3.15 | 2.54 | 3.15 | 3.70 | 4.32 |
| Total Shareholders' Equity | 521.92M | 233.06M | 245.84M | 268.08M | 275.16M | 222.94M | 205.46M | 224.67M | 152.52M | 179.25M | 184.52M | 213.65M |
| Common Stock | 8K | 7K | 6K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K |
| Retained Earnings | -521.72M | -477.21M | -431.08M | -404M | -391.7M | -438.59M | -452.02M | -428.17M | -397.86M | -365.89M | -332.64M | -297.75M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -4.75M | -3.83M | -3.25M | -3.37M | -3.33M | -3.36M | -2.32M | -2.67M | -2.69M | -2.72M | -1.46M | -1.64M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |